Phthalates, used as plasticizers, have become a ubiquitous contaminant and have been reported for their potential to induce toxicity in living organisms. Among them, di-isononyl phthalate (DiNP) has been recently used to replace di(2-ethylhexyl) phthalate (DEHP). Nowadays, there is evidence that DiNP is an endocrine-disrupting chemical; however, little is known about its effects on the endocannabinoid system (ECS) and lipid metabolism. Hence, the aim of our study was to investigate the effects of DiNP on the ECS in zebrafish liver and brain and on hepatic lipid storage. To do so, adult female zebrafish were exposed to three concentrations (0.42 mg/L, 4.2 mg/L, and 42 mg/L) of DiNP via water for 3 weeks. Afterwards, we investigated transcript levels for genes involved in the ECS of the brain and liver as well as liver histology and image analysis, Fourier-transform infrared spectroscopy imaging, and measurement of endocannabinoid levels. Our results demonstrate that DiNP upregulates orexigenic signals and causes hepatosteatosis together with deregulation of the peripheral ECS and lipid metabolism. A decrease in the levels of ECS components at the central level was observed after exposure to the highest DiNP concentration tested. These findings suggest that replacement of DEHP with DiNP should be considered with caution because of observed adverse DiNP effects on aquatic organisms. (Endocrinology 158: 3462-3476, 2017) 
the consumer products and environment can lead to chronic population exposure (3, (8) (9) (10) (11) (12) . To date, several studies have reported the endocrine-disrupting properties of phthalates, not only in humans, where they are linked to health disorders (13, 14) , but also in a wide range of aquatic and terrestrial organisms (15) (16) (17) (18) (19) .
Among the family of high-molecular-weight phthalates, di-isononyl phthalate [DiNP; Chemical Abstracts Service (CAS) No. 28553-12-0] has replaced the widely used chemical di(2-ethylhexyl) phthalate (DEHP), which is known for its adverse consequences in humans and wildlife (19) . DiNP has become one of the dominating alternatives of DEHP due to their similar properties (20) , except in medical products (1) . The globally forecasted growth in DiNP consumption between 2012 and 2018 represents nearly 5 times the current DEHP use in Europe (2) , where the family of high-molecular-weight phthalates (DiNP, di-isodecyl phthalate, and dipropylheptyl phthalate) holds a 57% share of the plasticizers market (2) .
Ninety-five percent of the manufactured DiNP is mainly used in PVC applications, and the other 5% is used in inks, adhesives, sealants, paints, and lubricants (21) . DiNP is also used widely in toys, food packaging, drinking straws, and gloves, among other consumable products. Like other members of the phthalate family, DiNP represents an ecological problem due to its weak bonding to the matrix and ease of release to the environment (9) . Thus, DiNP can leach into the food stored in plastics and be released in the environment (22) . Indeed, DiNP can be detected in frozen meals, oil, fat, and breads (23) . According to a European Union-sponsored study, DiNP exposures for adults were approximately 11mg/kg/ d, whereas exposures in children, from sources other than toys, were approximately 50mg/kg/d (22) . Although both estimates fall below the tolerable daily intake for DiNP, exposures of children could potentially reach higher via mouthing activities. So, since January 2014, DiNP use was restricted in toys and items for children under 3 years of age (Directive 2005/84/EC). In addition, the United States and Canada have implemented similar restrictions on the use of DiNP in toys and childcare articles that can be placed in the mouth, thus limiting to 0.1% the presence of DiNP.
Fortunately, like other phthalates, DiNP accumulation in tissues is not persistent (24) . DiNP appears in the liver and kidney shortly after ingestion, followed by catabolism and excretion via urine with a half-time of 7 hours. However, as for other phthalates, increased use of DiNP may lead to chronic exposure of organisms (23) . In this context, DiNP was detected in 72% of the species sampled by Mackintosh et al. (25) , confirming that the substance is bioavailable to aquatic biota.
Liver is one of the most sensitive organs following chronic exposure to DiNP (26, 27) , with possible toxicological consequences, based on a number of studies, including (1) hepatic alterations in SV129 wild-type mice after a week of exposure (28) and (2) non-neoplastic lesions, such as necrosis or spongiosis hepatis (24) , and hepatocellular enlargement among others in Fischer 344 rats exposed for 2 years (29) . In addition, DiNP has also been shown to exhibit peroxisome proliferator properties (28, 30) .
To date, several studies in mice have highlighted the toxicity of DiNP not only in the liver, but also in the brain. DiNP was shown to cause injury in hippocampus pyramidal brain cells as well as oxidative stress, leading to impaired cognitive abilities and anxiety-like behavior in exposed mice (31, 32) . In addition to the myriad of effects of DiNP, this compound was found to act as an estrogenic chemical in zebrafish and medaka (33) and cause abnormalities in androgen-dependent tissues in other species (34) (35) (36) . For instance, in rats exposed to DiNP, inhibitory effects on fetal testicular testosterone production and content, associated with the tendency to reduce plasma testosterone levels, were reported (37) .
Recently, the endocannabinoid system (ECS) has emerged as a key player in the regulation of energy homeostasis and food intake (38) (39) (40) and a metabolic mediator from the central nervous system to the periphery, and vice versa (39) . The ECS is comprised of two G-protein-coupled receptors [cannabinoid receptor type 1 (CB1) and cannabinoid receptor type 2 (CB2)], two endogenous ligands (the endocannabinoids [ECs] N-arachidononyl-ethanolamine [anandamide (AEA)] and 2-arachidononyl-glycerol [2-AG]), and the enzymes regulating the levels of ECs. The metabolic enzymes are the N-acylphosphatidylethanolamine-specific phospholipase D (NAPE-PLD) and sn-1-diacylglycerol lipase a (DAGLa) for the biosynthesis of AEA and 2-AG, respectively. AEA is mainly catabolized by the fatty acid amide hydrolase (FAAH), and 2-AG by monoacylglycerol lipase, into arachidonic acid plus ethanolamine and glycerol, respectively. Some studies have shown that the dysregulation of the components of the ECS is associated with several metabolic disorders compromising the well-being of the organisms. For example, in the liver, which is one of the major organs involved in energy homeostasis, the ECS may be a contributing factor in inducing steatotic liver through disruption of hepatic lipogenic and lipolytic pathways (38) . The activation of CB1 in hepatocytes induces the synthesis of lipogenic enzymes and increases de novo fatty acid production (41, 42) , whereas CB2 activation, instead, reduces adipose tissue and liver inflammation (43) .
In addition to the peripheral control, an important role is exerted by the ECS at the central level (44) , where CB1 is the most abundant G-protein-coupled receptor in the mammalian brain (45) , and ECs work as rapidly as produced and are quickly deactivated (40) . It is well established that CB1 receptor agonists or antagonists strongly affect feeding behaviors (40) , and activation of CB1 leads to stimulation of food intake (39) , whereas a reduction in the activity by an antagonist leads to reduced food consumption (44) .
Nevertheless, in spite of DiNP's potential noxious effects on lipid metabolism and energy homeostasis as previously mentioned, to date, no reports are available on how the plastic component DiNP may interfere with the ECS. Thus, the main objective of this study was to evaluate the effect of this relatively new plasticizer administered via water on Danio rerio metabolism. For the accomplishment of our objectives, the expression of several key genes of lipid metabolism, ECS, and appetite control have been analyzed in the liver and brain of zebrafish exposed for 3 weeks to environmentally relevant concentrations of DiNP (22, 46, 47) . In addition, we measured ECS in the liver and brain and investigated histology as well as biochemical composition of the liver by Fouriertransform infrared spectroscopy (FT-IR) imaging.
Materials and Methods

Animals and DiNP treatment
The experiments and the analysis were carried out exclusively with adult female zebrafish (Danio rerio; wild-type strain) to contain the number of specimens to be treated and killed as well as to avoid possible bias related to sex difference of endocrine-disrupting chemical (EDC) by acting through sexspecific pathways. The specimens used were 1-year-old females that were sexually mature.
A 3-week treatment with DiNP was conducted in duplicate. For each replicate, a final housing density of 25 female zebrafish were placed per tank according to protocols and procedures approved by the University of Calgary Animal Care Committee (protocol no. AC15-0183). Three nominal concentrations of DiNP [42 mg/L (10 7 M), 4.2 mg/L (10 8 M), and 0.42 mg/L (10 9 M) (99% purity, Sigma-Aldrich, Milan, Italy)] were used in 100-L aquaria supplied with oxygenated water and controlled conditions (28.0°C 6 0.5°C under a 14-hour/10-hour light/dark period). The specimens were fed twice per day with a 1:1 mixture of adult zebrafish complete diet (Zeigler Bros., Inc., Gardners, PA) and live brine shrimp nauplii (Artemia cysts).
Due to the lack of data regarding the concentrations of DiNP in water, nominal doses administrated to zebrafish were chosen after careful review of previously published papers (46, 47) and taking into account the predicted DiNP concentration in water surface by the European Community, which is 0.7 mg/L (22) . A molecular weight of 420 g/mol and its multiples were used for the calculation of DiNP molar concentrations.
After 21 days of treatment, fish were euthanized with buffered MS-222 (3-aminobenzoic acid ethyl ester; SigmaAldrich, St. Louis, MO) according to the University of Calgary Animal Care Committee (protocol no. AC15-0183) and sampled at 7:00 to 9:00 AM to avoid any possible circadian variability. Livers and brains from each experimental group were removed, immediately frozen on dry ice, and transported to the analytical laboratory, where they were stored at -80°C for FT-IR, RNA extraction, and endocannabinoid assays. Livers were fixed in Bouin solution for histology.
RNA extraction and complementary DNA synthesis
Total RNA was isolated from liver and brain with RNAzol solution (Sigma-Aldrich) according to the manufacturer's instructions and as described previously (48) . Final RNA concentrations were determined with a NanoDrop 1000 Spectrophotometer (Thermo Scientific), whereas RNA integrity was verified by red staining of 28S and 18S ribosomal RNA bands on a 1% agarose gel. Then 3 mg total RNA was used for complementary DNA (cDNA) synthesis with iScript cDNA Synthesis Kit (Bio-Rad, Milano, Italy) and kept at -20°C until use.
Real-time quantitative polymerase chain reaction
The relative quantification of gene expression was performed with the SYBR green method in an iQ5 Multicolor RealTime PCR Detection System (Bio-Rad) as described previously (48) . Primer list is reported in Table 1 and used at a final concentration of 10 pmol/mL.
Two different genes, namely acidic ribosomal phosphoprotein (Arp) and ribosomal protein L13a (Rpl13a), were used as internal controls (49, 50) to minimize variations in messenger RNA (mRNA) and cDNA quantity and quality. Reference genes were chosen because the mRNA levels did not vary between experimental treatments. No amplification product was observed in the negative control (absence of template). Specificity of primer and the absence of primer-dimer formation were indicated by a single peak in the dissociation curve obtained at the end of the amplification cycle.
Data were analyzed using the iQ5 Optical System version 2.1 (Bio-Rad). The quantification method was based on a DDcycle threshold calculation implemented with the Pfaffl equation. Data were generated in duplicate from five biological replicates and expressed as relative mRNA levels (unscaled abundance).
Measurement of ECs AEA and 2-AG and EC-like mediators palmitoylethanolamide and oleoylethanolamine in the brain and liver
The extraction, purification, and quantification of ECs from tissues were performed as previously described (51) . Briefly, the tissues were dounce-homogenized and extracted with chloroform/ methanol/Tris-HCl (50 mmol L 
FAAH enzymatic activity
A pool of five livers were homogenized at 4°C in 50 mM Tris-HCl buffer (pH 7.0) and centrifuged at 800g, and the supernatant was collected and centrifuged at 10,000g. Protein concentrations were measured by Bradford assay (Bio-Rad). Seventy micrograms of protein from liver membranes was incubated with [ 
Liver morphology
The liver samples (n = 7/experimental group) were fixed in Bouin and prepared for histological examination using standard biological procedures. The fixed tissues were embedded in paraffin and sectioned (4 mm) with a microtome (Leitz 1512). Each liver was fully sectioned and processed for Mayer hematoxylin-eosin staining and observed under a Zeiss Axioskop microscope. Microphotographies were captured using a high-resolution digital camera (Canon EOS 6D).
Area covered with lipids vacuoles in the liver
The estimate of hepatic lipid area was done according to the methodology of Papadakis et al. (52) . For each liver, five microphotographs were obtained at 3100 magnification from different areas of the liver. A total number of 140 photographs were analyzed with ImageJ (https://imagej.nih.gov/ij/).
FT-IR
FT-IR measurements were carried out by using a Bruker VERTEX 70 interferometer coupled with the Hyperion 3000 Vis-IR microscope and equipped with a liquid nitrogen-cooled bidimensional focal plane array detector (area size, 64 3 64 pixels) as described previously (53) .
Statistical analysis
The statistical analyses on gene expression, EC levels, FAAH enzymatic activity, and FT-IR were performed with one-way analysis of variance (ANOVA) followed by a post hoc Tukey test. Data fulfilled the conditions for applying a parametric test, and log-normalization to homogenize the variance was used when needed. Confidence interval was set at 95% (P , 0.05). Results are presented as mean 6 standard deviation (SD). Statistical analysis for hepatic histology was also performed using ANOVA, but the results are expressed in percentage and reported as mean 6 SD. All statistical procedures were run using GraphPad Prism 6.
Results
DiNP alters central cnr1 and cnr2
We first tested whether DiNP modulates zebrafish ECS at the central level, including the genes encoding for the main receptors and the enzymes in charge of the synthesis and catabolism of the EC. Hence, the genes encoding CB1 and CB2 (i.e., cnr1 and cnr2) in the brain were Fig. 1(B) ].
DiNP upregulates appetite signals
In the line of the results previously described and because ECS is deeply involved in the regulation of food intake, the main signals for the appetite were studied to confirm if such EDC may induce alterations in the appetite regulation in the brain. Hence, the exposure to 0.42 mg/L and 4.2 mg/L DiNP resulted in a significant increase in the transcript levels for npy, which is an orexigenic neuropeptide with an important role in the modulation of food intake and obesity (Fig. 2) 
DiNP modulates ECS peripheral signals
As described above, liver is one of the main DiNP targets. Following the altered results at the central level, the same ECS markers were also tested at the hepatic level. Indeed, the exposure to DiNP increased the mRNA levels of the principal EC receptors cnr1 and cnr2 in the liver in a dose-related manner. Transcript level for ppara was also increased following exposure with the 0.42 and 4.2 mg/L DiNP, whereas pparg mRNA level was not affected [ Fig. 3(A) ]. Regarding the control of EC level, exposure to all concentrations of DiNP significantly decreased transcription of genes encoding the enzymes synthesizing AEA, including nape-pld and abdh4. However, the DiNP treatment did not affect the transcription of faah, which encodes the enzyme hydrolyzing AEA, but significantly reduced the mRNA level for the cox-2 catabolic enzyme at all concentrations tested [ Fig.  3(B) ]. On the other hand, DiNP exposure at lower concentrations (0.42 and 4.2 mg/L) increased the transcripts for dagla and mgll genes that encode 2-AG synthetic and hydrolytic enzymes, respectively.
DiNP induces de novo hepatic fatty acid synthesis and steatosis by modulating lipogenic and lipolytic gene expression
Once established that DiNP induced alterations at the ECS level, we wanted determine whether DiNP-induced hepatosteatosis was associated with the ECS variations. We observed that DiNP exposure was without effect on fasn transcript level (the enzyme that catalyzes the synthesis of long-chain saturated fatty acids), but increased transcription level for agpat4 (the enzyme for de novo phospholipid biosynthesis) (Fig. 4) . As for the lipogenic enzymes, DiNP exposure decreased transcription for dgat2 (the enzyme involved in the final reaction of triglyceride synthesis), as well as dgat2, acox-3, and acat-2 (key enzymes of the b-oxidation of lipids and sterol synthesis), hnf4a (a major transcriptional regulator of many genes related to lipid homeostasis in the liver and a marker of liver condition), and lepr in the liver. In this organ, the level of leptin is directly correlated with the expression of its receptor (54) , and it is involved in energy homeostasis and accumulation of fat. We also performed histological analyses on the liver after we saw the alteration of the molecular markers revealing severe lipid accumulation in the hepatic tissue of animals exposed to DiNP [ Fig. 5(A) ]. Cytosolic lipid accumulation was normally accompanied by a loss of hepatocyte shape and ultimately the hepatic architecture. These postulates are supported by the observed increase of the area of the liver covered by lipids following treatments [ Fig. 5(B) ].
Effect of DiNP on EC and EC-like mediator levels in zebrafish brain and liver
Considering the molecular results at central and peripheral levels regarding the ECS pathway, the levels of ECs (AEA and 2-AG) and EC-like mediators (PEA and OEA) were measured in zebrafish brains and livers after chronic exposure to DiNP. In the brain (Table 2 ), the 4.2 and 42 mg/L concentrations induced a 50% reduction of the most abundant EC, AEA, but did not affect the 2-AG level. The levels of PEA and OEA were reduced by all the treatments, but only the highest concentrations of DiNP significantly decreased OEA levels. On the other hand, DiNP treatments generally increased AEA levels in the hepatic tissue (Table 3) , although only the 4.2 and 42 mg/L concentrations were statistically significant. Accordingly, the activity of FAAH, the main catabolic enzyme of AEA, was reduced by all the treatments (Fig. 6) ; however, the levels of 2-AG remained unchanged. In terms of the EClike mediators, PEA level was significantly increased following exposure to 0.42 and 4.2 mg/L DiNP, whereas the same doses reduced the OEA levels. Surprisingly, neither PEA nor OEA levels were affected following the exposure to the highest DiNP concentration.
DiNP modifies the biochemical composition of liver, increasing lipidic content
To confirm the ability of DiNP to alter the lipid metabolism in the liver, we investigated whether DiNP can modify lipids by FT-IR analysis. Three randomly selected areas were chosen among all liver sections to determine chemical composition. was indicative of the total cellular biomass of the selected area considered (cell). All of the values indicative of hepatic fat characteristics were normalized to the cell value. These bands were chosen to quantitatively locate the presence and the characteristics of hepatic fat. Chemical maps integrated under lipids gave a visible display with a false color scale [ Fig. 7(A) ]. The intensity of the signal associated with a specific band provide information on both the presence and the localization of the molecular/chemical group, and as we saw, the intensity increased concomitantly with the doses of the phthalate applied. A quantitative analysis was also performed as shown in Fig. 7(B) for lipids, where the quantity and quality of lipids were analyzed. All treatments modified the cell composition by increasing the amounts of lipids, specifically the triglycerides. Regarding the characteristics of the lipids, surprisingly, all the treatments increased the length of the aliphatic chain (CH 2 / CH 3 ratio).
Discussion
Recent reports demonstrated how certain environmental chemicals can induce obesity by promoting adipogenesis and disrupting some basic physiological functions (55, 56) . Among the myriad of chemicals exhibiting this effect (56), common plasticizers such as phthalates are noteworthy. Many studies have been published regarding the obesogenic activity and the promotion of metabolic disorders induced by different phthalates in humans (57, 58) and rodents (55, 59) and in the aquatic model, zebrafish; however, the literature about DiNP is still scarce. Regarding the ECS, the cannabinergic pathway, which is one of the major circuits for appetite and body weight regulation, would be a perfect candidate to test the obesogenic property of pollutants (56, 60) . ECS deregulation has been mainly studied in humans and rodents. However, more recently, using zebrafish as an experimental model, it was demonstrated that exposure to bisphenol A (BPA) increases hepatosteatosis by upregulating ECS signaling (61) . The current study provides information on adverse effects of environmentally relevant concentrations of another EDC, DiNP, on metabolic abnormalities at the ECS level using a well-established approach. Alterations of ECS can in turn effect the regulation of food intake and energy homeostasis. Initially, it was thought that the control of energy intake by the ECS occurred mainly centrally via the regulation of several hypothalamic anorexic and orexigenic mediators. However, there is evidence that the ECS, particularly via activation of CB1 receptors, also plays a role in controlling peripheral organs such as liver involved in food intake and energy balance (44) . At the central level, the neuromodulatory role of ECs through CB1 receptors in brain areas controlling food intake is well established. Furthermore, the ECS may influence the expression and action of several hypothalamic anorexic and orexigenic mediators, such as NPY (62) . NPY is a well-studied, potent orexigenic neuropeptide and a promoter of lipid storage (63) . In the current study, we found an upregulation of the genes encoding for NPY and CB1 (i.e., npy and cnr1) induced by the 0.42 and 4.2 mg/L concentrations of DiNP in the zebrafish brain, suggesting that NPY may require CB1 to exert its orexigenic effects, as previously demonstrated by Gamber et al. (62) in rats. Focusing on the results obtained here in the zebrafish brain, it appears that, at lower concentrations (0.42 and 4.2 mg/L), DiNP may regulate appetite via CB1, whereas, at higher concentrations, it may do so via CB2, as it was demonstrated in chickens and mice (64, 65), although so far there has been no Each point consists in the analysis of five pictures randomly taken in each liver, with a total of seven livers per experimental group and expressed as a percentage in respect to the total area of the hepatic tissue (mean 6 SD, P , 0.05). Letters above each column indicate statistical differences among groups (P , 0.05 vs untreated controls; ANOVA followed by Tukey multiple comparison test). CTRL, control.
evidence that CB2 is involved in food intake in other species of mammals or fishes. We also found an increase of mc4r expression at the higher DiNP concentration, suggesting that the receptor encoded by this gene, which is strongly anorexigenic, may counteract the orexigenic effects of the pollutant. To gain further insight into the effects of DiNP on the brain, we determined mRNA levels of the leptin receptor gene lepr. Leptin, produced in the liver of teleost fishes, binds to specific receptors in the brain, where it reduces food intake by downregulating orexigenic factors, such as NPY (66) . We found levels of brain lepr expression to be unchanged, suggesting that the increase of orexigenic factors such as cnr1, npy, and cnr2 may not be associated with actions of this hormone in the zebrafish brain. However, we did not measure the circulating levels of leptin and hence cannot exclude its role in DiNP effects.
Following with the ECS, DiNP exposure reduced AEA level and was without effect on 2-AG in the brain, which is different from the observed increases in the expression of the main EC receptor or the metabolic enzymes (napepld, abdh4, faah, mgll, and dagla). Similarly, discrepancies were observed following exposure with BPA by Martella et al. (61) in zebrafish, where the brain concentrations of EC did not change, despite the upregulation of cnr1 at the central level. The observed reduced level of EC-like compound OEA, which is known to reduce food intake in rodents via activation of PPARa (67, 68) , is consistent with the report by Martella et al.
(61) following BPA administration, suggesting that OEA could also play a role in the enhancement of appetite together with enhanced CB1 expression. Thus, taken together, these results lead us to the hypothesis that a negative feedback on ECS signaling might occur in the brain following contaminant-induced upregulation of CB1 (and CB2) levels.
At the peripheral level, all DiNP concentrations caused a dose-related rise of hepatic fat as evidenced by histological and FT-IR analysis. To our knowledge, this is the first study describing the ability of DiNP to induce fatty liver in zebrafish. However, several papers reported the steatotic properties of many phthalates in zebrafish, such as diethyl phthalate in zebrafish embryos (69) or dibutyl phthalate in adults (70) . It is well stablished that, at the hepatic level, the ECS may contribute to fatty liver through disruption of lipogenic and lipolytic pathways. For instance, it has been demonstrated that activation of CB1 by AEA induces steatosis in mice (42, 71) , whereas CB1 pharmacological blockade or genetic inactivation in hepatocytes reverses hepatic steatosis (72) . In our study, hepatic cnr1 expression was only upregulated by the highest DiNP concentration, although the transcripts for the other main EC receptor, CB2 (cnr2), and the content of lipids were increased in all groups. Similar to obese mice, in which an increase of Cnr2 mRNA levels was measured (43) , in zebrafish, cnr2 also seems to be a biomarker for (rather than the cause of) steatosis. The observed increase in the hepatic level of AEA and the unchanged level of 2-AG in the groups exposed to DiNP are consistent with reported results in mice fed with a high-fat diet and developing fatty liver (42) and in zebrafish exposed to BPA (61) , supporting the concept that increased AEA and, hence, CB1 activity, is one of the pathways for the appearance of steatosis. The increase of hepatic AEA levels in the current study, however, was not correlated with changes in the expression of genes coding for its synthetic enzymes, nape-pld and abdh4, which were in fact down-regulated in the treated fish. On the other hand, there was a decrease in the activity of FAAH in the liver and a reduction in the transcript abundance of another EC-degrading enzyme, cox-2, following exposure to DiNP that might explain the increased AEA levels (61) . Also, BPA-induced downregulation of FAAH expression and/or activity was suggested as the cause of the enhancement of hepatic AEA levels (61) . We hypothesize that an increased level of AEA leads to a negative feedback mechanism leading to lower levels of nape-pld and abdh4 expression to avoid further increase in the level of AEA in the liver. On the other hand, increases induced by DiNP in the expression of the major enzymes catalyzing 2-AG biosynthesis (DAGLa) and inactivation (MGLL) may in part be a compensatory mechanism minimizing change in hepatic 2-AG levels following exposure to the phthalate. Regarding the EClike mediators, PEA and OEA are endogenous ligands of PPARa, and the latter compound can stimulate lipolysis (42) via this nuclear receptor, independent of CB1 in the liver. Hence, the lower hepatic OEA levels found in DiNP-exposed zebrafish might explain the steatotic condition, and the observed increase in ppara may be part of an adaptive response to minimize the consequences of elevated AEA and reduced level of OEA. On the other hand, the increased levels of hepatic PEA induced by DiNP might be related to its anti-inflammatory actions because high levels of this mediator have been found during inflammatory processes (73) , of which steatosis is an example.
A considerable amount of studies suggests that PPARa agonists exert several effects in the rodent liver, such as hepatomegaly, cell proliferation, peroxisome proliferation, and glucose and lipid metabolism among others (74) (75) (76) ; such effects are not present in PPARanull animals (28, 77) . Interestingly, DiNP per se is considered a PPARa and PPARg agonist in humans and rodents (28, 30, 78) , promoting b-oxidation of fatty acids (79) . The observed stimulatory effect of DiNP on ppara expression is in agreement with previous studies [see review by Grün and Blumberg (56) ] and is consistent with the idea that this phthalate, like a number of others xenobiotics, may interact with PPARs, leading to disruption of adipogenesis and related transcriptional signaling.
However, DiNP did not exclusively alter the ECS, but also affected several metabolic key markers such as leptin receptor (lepr) in the liver. Different from its role at the central level, deficiency of peripheral leptin signaling can lead to increased storage of lipids in rodent liver (80) and hence participate in the hepatic steatosis observed in zebrafish. In addition, increased expression of agpat-4, encoding for an enzyme involved in the second step of de novo lipid biosynthesis, supports our hypothesis that DiNP disrupts the metabolic processes in zebrafish. In contrast, we observed a decrease in dgat2 transcript level, which is involved in the second step of the lipid biosynthesis. Commonly, during steatosis, dgat2 is overexpressed; however, in dgat-deficient mice, the synthesis of triglycerides still occurs (81) as in our study, where the abundance of triglycerides with respect to the total amount of lipids augmented following exposure to increasing concentrations of DiNP. It is interesting to note that, in the fungus Mortierella ramanniana, DGAT2 possesses higher preference for medium-chain than longchain substrates (82) . Consequently, another explanation for the drastic downregulation of this enzyme might lie in the higher availability of fatty acids with a longer aliphatic chain, as shown in our study by FT-IR. A similar downregulation was found for acat2, a gene encoding an enzyme related to the hepatic triglyceride metabolism. In this context, ACAT2 knockout mice are protected against lipid accumulation and present lower levels of hepatic triglycerides (83) . In the light of the results reported here, we therefore hypothesize that dgat2 and acat2 were downregulated, probably as an adaptive response to the high level of steatosis, to mitigate the overproduction of triglycerides without affecting fasn expression.
Adding further evidence of the metabolic impairment induced by DiNP, two other markers for steatosis such as hnf4a and acox-3 were drastically downregulated by the phthalate. The hnf4a is a major regulator of genes involved in the control of lipid homeostasis in liver (84) , and studies with hnf4a-deficient livers revealed excessive lipid accumulation in mouse hepatocytes (84, 85) . Similarly, acox-3 is involved in the b-oxidation of fatty acids, and acox-3-deficient mice showed hepatomegaly with steatosis (86) , in agreement with our histological and biochemical results, where all the treatments with DiNP induced an increase of lipids in the hepatic tissue. Therefore, unlike the alterations of dgat2 and acat2 https://academic.oup.com/endoexpression, those induced by DiNP on hnf4a and cox-3 expression might be among the causes, and not the consequences, of DiNP-induced steatosis.
In conclusion, the results obtained here and summarized in Fig. 8 indicate that environmental concentrations of DiNP, a widely-used plasticizer, induce an impairment of lipid metabolism, hepatic steatosis, and a dysregulation of the central and peripheral ECSs in zebrafish. As a consequence of the current study, the industry and regulators should be more cautious about the use and release of DiNP in the environment. Our observations provide a basis for future studies on the mechanisms of action of DiNP, which is now a common environmental contaminant, and these findings would also be relevant to a more accurate assessment of the potential ecological impact of emerging pollutants in the aquatic ecosystems.
